+1 877 302 8632
+1 888 205 9894 (Toll-free)

SARS-CoV-2 Protein Interaktom

SARS-CoV-2 is an enveloped, positive-sense, single-stranded RNA beta coronavirus belonging to the order of nidovirales. In the first three months since its initial identification in December 2019 SARS-CoV-2 has caused more than 800.000 confirmed cases and over 40.000 fatalities worldwide of the associated severe acute respiratory syndrome COVID-19 (coronavirus disease 2019)1.

Presently, no vaccine is available to curb the virus’ spread. A potential source for COVID-19 therapeutics are existing antiviral reagents that are either already approved or in development for the treatment of the other two respiratory syndromes – SARS and MERS – caused by human coronaviruses (hCoVs)2,3. A deeper understanding of the function of the virus and its proteins is essential for the targeted application of existing drugs and the discovery of new ones4,5,6.

The 30kb SARS-CoV-2 genome encodes 16 non-structural proteins (Nsp1-16), four structural proteins (spike, envelope, nucleocapsid, membrane), and nine putative accessory factors7. Many of these proteins and polypeptides have a number or interaction partners in particular in lung cells, the virus’ primary infection site. These interactions with the host cell determine the virus’ ability to infect the cell, reproduce its genome and trigger the production and release of new virus particles. In addition, several virus proteins appear to have interaction partners affecting innate immune pathways such as the interferon signaling pathway, NF-kappa B inflammatory response, type I interferon production, and IRF-3 activation.

At least some of the members of the third group of SARS-CoV-2 proteins, the nine accessory factors (Orf3a-10), have been implicated in driving progression of COVID-19. Orf3a induces apoptosis and is thought to activate NF-kB and the NLRP3 inflammasome involved in pyroptosis, a highly inflammatory form of apoptosis. The type I interferon (IFN) antagonists Orf6 and Orf9b inhibit the IFN response, the most important innate antiviral cytokines.

Some of these regulatory functions are shared with other pathogenic human viruses. Therefore, a deeper understanding of these mechanisms may lead to the identification of targets and development of novel therapeutics relevant for future virus pandemics.

SARS-CoV-2 Structural Proteins: SARS-CoV-2 Spike Protein, SARS-CoV-2 Nucleocapsid Protein, SARS-CoV-2 S1 (RBD) Protein, SARS-CoV-2 Spike Subunit S1 Protein, SARS-CoV-2 Subunit S2 Protein

SARS-CoV-2 Non-Structural Proteins: SARS-CoV-2 Non-Structural Proteins

SARS-CoV-2 Antibodies: anti-SARS-CoV-2 Antibodies

SARS-CoV Viral Proteins: , , , ,

Additional information and products: CoV-2 Resource, SARS-CoV-2 RT-PCR and qPCR Kits, SARS-CoV-2 ELISA Kits, SARS-CoV-2 Life Cycle Stages & Inhibition Targets


  • Dong, Ensheng; Du, Hongru; Gardner, L. An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect. Dis. (2020).
  • Morse, J. S., Lalonde, T., Xu, S. & Liu, W. R. Learning from the Past: Possible Urgent Prevention and Treatment Options for Severe Acute Respiratory Infections Caused by 2019-nCoV. Chembiochem 21, 730–738 (2020).
  • Li, G. & De Clercq, E. Therapeutic options for the 2019 novel coronavirus (2019-nCoV). Nat. Rev. Drug Discov. 19, 149–150 (2020).
  • Báez-Santos, Y. M., St. John, S. E. & Mesecar, A. D. The SARS-coronavirus papain-like protease: Structure, function and inhibition by designed antiviral compounds. Antiviral Res. 115, 21–38 (2015).
  • Kirchdoerfer, R. N. & Ward, A. B. Structure of the SARS-CoV nsp12 polymerase bound to nsp7 and nsp8 co-factors. Nat. Commun. 10, 2342 (2019).
  • Coutard, B. et al. The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade. Antiviral Res. 176, 104742 (2020).
  • David E. Gordon, Gwendolyn M. Jang, Mehdi Bouhaddou, Jiewei Xu, Kirsten Obernier, Matthew J. O’Meara, Jeffrey Z. Guo, Danielle L. Swaney, Tia A. Tummino, Ruth Huettenhain, Robyn M. Kaake, Alicia L. Richards, Beril Tutuncuoglu, Helene Foussard, Jyoti Batra, N. J. K. A SARS-CoV-2-Human Protein-Protein Interaction Map Reveals Drug Targets and Potential Drug Repurposing. Nature. (2020).

CoV-2 Spike Protein

CoV-2 Nucleocapsid Protein

RRP9 - Ribosomal RNA Processing 9, Small Subunit (SSU) Processome Component, Homolog (Yeast):

UPF1 - UPF1 Regulator of Nonsense Transcripts Homolog (Yeast):

MOV10 (Mov10, Moloney Leukemia Virus 10, Homolog (Mouse)):

G3BP2 (GTPase Activating Protein (SH3 Domain) Binding Protein 2):

PABPC4 - Poly(A) Binding Protein, Cytoplasmic 4 (Inducible Form):

G3BP1 - GTPase Activating Protein (SH3 Domain) Binding Protein 1:

LARP1 (La Ribonucleoprotein Domain Family, Member 1):

FAM98A (Family with Sequence Similarity 98, Member A):

PABPC1 - Poly(A) Binding Protein, Cytoplasmic 1:

DDX21 (DEAD (Asp-Glu-Ala-Asp) Box Polypeptide 21):

CoV-2 Envelope Protein

ZC3H18 (Zinc Finger CCCH-Type Containing 18):

Cwc27 (CWC27 Spliceosome-Associated Protein Homolog (S. Cerevisiae)):

SLC44A2 (Solute Carrier Family 44, Member 2):

AP3B1 (Adaptor-Related Protein Complex 3, beta 1 Subunit):

CoV-2 Membrane Protein

AASS - Aminoadipate Semialdehyde Synthase:

PSMD8 - Proteasome (Prosome, Macropain) 26S Subunit, Non-ATPase, 8:

PMPCB - Peptidase (Mitochondrial Processing) beta:

FAM8A1 - Family with Sequence Similarity 8, Member A1:

YIF1A - Yip1 Interacting Factor Homolog A (S. Cerevisiae):

TUBGCP2 (Tubulin, gamma Complex Associated Protein 2):

PMPCA - Peptidase (Mitochondrial Processing) alpha:

Slc25a21 - Solute Carrier Family 25 (Mitochondrial Oxodicarboxylate Carrier), Member 21:

TARS2 - threonyl-tRNA Synthetase 2, Mitochondrial (Putative):

FASTKD5 - FAST Kinase Domains 5:

C20orf4 - Chromosome 20 Open Reading Frame 4:

TUBGCP3 (Tubulin, gamma Complex Associated Protein 3):

SLC30A9 - Solute Carrier Family 30 (Zinc Transporter), Member 9:

BZW2 (Basic Leucine Zipper and W2 Domains 2):




TIMM10 (Translocase of Inner Mitochondrial Membrane 10 Homolog (Yeast)):

DNAJC11 (DnaJ (Hsp40) Homolog, Subfamily C, Member 11):

ALG11 - Asparagine-Linked Glycosylation 11, alpha-1,2-Mannosyltransferase Homolog (Yeast):

TIMM9 - Translocase of Inner Mitochondrial Membrane 9 Homolog (Yeast):




ATP5L (ATP Synthase, H+ Transporting, Mitochondrial Fo Complex, Subunit G):

ATP13A3 (ATPase Type 13A3):

ATP6AP1 - ATPase, H+ Transporting, Lysosomal Accessory Protein 1:


FAM162A - Family with Sequence Similarity 162, Member A:

NAT14 - N-Acetyltransferase 14 (GCN5-Related, Putative):

NDUFAF2 - NADH Dehydrogenase (Ubiquinone) 1 alpha Subcomplex, Assembly Factor 2:

QSOX2 (Quiescin Q6 Sulfhydryl Oxidase 2):

MOGS - Mannosyl-Oligosaccharide Glucosidase:

Acsl3 (Acyl-CoA Synthetase Long-Chain Family Member 3):

RAB2A - RAB2A, Member RAS Oncogene Family:

GNB1 (Guanine Nucleotide Binding Protein (G Protein), beta Polypeptide 1):

RAB18 (RAB18, Member RAS Oncogene Family):


MRPS2 (Mitochondrial Ribosomal Protein S2):

NOL10 (Nucleolar Protein 10):

MPHOSPH10 - M-Phase phosphoprotein 10 (U3 Small Nucleolar Ribonucleoprotein):

SEPSECS (Sep (O-phosphoserine) tRNA:Sec (Selenocysteine) tRNA Synthase):

MRPS5 (Mitochondrial Ribosomal Protein S5):

NARS2 - Asparaginyl-tRNA Synthetase 2, Mitochondrial (Putative):

MRPS27 - Mitochondrial Ribosomal Protein S27:

SRP19 (Signal Recognition Particle 19kDa):

SRP54 (Signal Recognition Particle 54kDa):

SRP72 (Signal Recognition Particle 72kDa):

WHSC1 (Wolf-Hirschhorn Syndrome Candidate 1):


SPG20 (Spastic Paraplegia 20 (Troyer Syndrome)):

DCAF7 (DDB1 and CUL4 Associated Factor 7):

GTF2F2 - General Transcription Factor IIF, Polypeptide 2, 30kDa:

MIB1 - Mindbomb E3 Ubiquitin Protein Ligase 1:

EIF4H (Eukaryotic Translation Initiation Factor 4H):


ERGIC1 - Endoplasmic Reticulum-Golgi Intermediate Compartment (ERGIC) 1:

AP2A2 (Adaptor-Related Protein Complex 2, alpha 2 Subunit):



LARP4B (La Ribonucleoprotein Domain Family, Member 4B):

SLU7 (SLU7 Splicing Factor Homolog (S. Cerevisiae)):

USP54 (Ubiquitin Specific Peptidase 54):

MYCBP2 (MYC Binding Protein 2):

PLEKHA5 (Pleckstrin Homology Domain Containing, Family A Member 5):

PRRC2B (Proline-Rich Coiled-Coil 2B):

PPIL3 - Peptidylprolyl Isomerase (Cyclophilin)-Like 3:

ZC3H7A (Zinc Finger CCCH-Type Containing 7A):

UBAP2L (Ubiquitin Associated Protein 2-Like):

Znf318 - Zinc Finger Protein 318:


CLIP4 (CAP-GLY Domain Containing Linker Protein Family, Member 4):

C1ORF50 (Chromosome 1 Open Reading Frame 50):

PDE4DIP - phosphodiesterase 4D Interacting Protein:

TLE1 (Transducin-Like Enhancer of Split 1 (E(sp1) Homolog, Drosophila)):

TLE3 (Transducin-Like Enhancer of Split 3 (E(sp1) Homolog, Drosophila)):

JAKMIP1 (Janus Kinase and Microtubule Interacting Protein 1):

USP13 (Ubiquitin Specific Peptidase 13 (Isopeptidase T-3)):

GCC2 - GRIP and Coiled-Coil Domain Containing 2:

CIT (Citron (Rho-Interacting, serine/threonine Kinase 21)):

PRKAR2A - Protein Kinase, CAMP-Dependent, Regulatory, Type II, alpha:

CEP250 (Centrosomal Protein 250kDa):

NIN - Ninein (GSK3B Interacting Protein):

AKAP9 (A Kinase (PRKA) Anchor Protein (Yotiao) 9):

GORASP1 - Golgi Reassembly Stacking Protein 1, 65kDa:

CEP350 (Centrosomal Protein 350kDa):

CDK5RAP2 (CDK5 Regulatory Subunit Associated Protein 2):





VPS39 (Vacuolar Protein Sorting 39 Homolog (S. Cerevisiae)):

VPS11 - Vacuolar Protein Sorting 11 Homolog (S. Cerevisiae):

SUN2 (Sad1 and UNC84 Domain Containing 2):

ALG5 (Asparagine-Linked Glycosylation 5, Dolichyl-Phosphate beta-Glucosyltransferase Homolog (S. Cerevisiae)):



HEATR3 (HEAT Repeat Containing 3):

MDN1 - MDN1, Midasin Homolog (Yeast):


CISD3 (CDGSH Iron Sulfur Domain 3):

KDELC2 (KDEL (Lys-Asp-Glu-Leu) Containing 2):

FOXRED2 - FAD-Dependent Oxidoreductase Domain Containing 2:

TOR1A - Torsin Family 1, Member A (Torsin A):

GGH - gamma-Glutamyl Hydrolase (Conjugase, Folylpolygammaglutamyl Hydrolase):

OS9 (Osteosarcoma Amplified 9, Endoplasmic Reticulum Lectin):

EDEM3 (ER Degradation Enhancer, Mannosidase alpha-Like 3):

UGT2 - UDP-Glucose Glycoprotein Glucosyltransferase 2:

CHPF (Chondroitin Polymerizing Factor):

PLEKHF2 - Pleckstrin Homology Domain Containing, Family F (With FYVE Domain) Member 2:

PCSK6 (Proprotein Convertase Subtilisin/kexin Type 6):

SIL1 (SIL1 Homolog, Endoplasmic Reticulum Chaperone (S. Cerevisiae)):



PIGS - Phosphatidylinositol Glycan Anchor Biosynthesis, Class S:

TAPT1 (Transmembrane Anterior Posterior Transformation 1):

TMED5 (Transmembrane Emp24 Protein Transport Domain Containing 5):

NLRX1 (NLR Family Member X1):

NDUFB9 - NADH Dehydrogenase (Ubiquinone) 1 beta Subcomplex, 9, 22kDa:

FAM134C (Family with Sequence Similarity 134, Member C):

ACAD9 - Acyl-CoA Dehydrogenase Family, Member 9:

ALG8 (Asparagine-Linked Glycosylation 8, alpha-1,3-Glucosyltransferase Homolog (S. Cerevisiae)):

NDUFAF1 - NADH Dehydrogenase (Ubiquinone) 1 alpha Subcomplex, Assembly Factor 1:

DPY19L1 (Dpy-19-Like 1 (C. Elegans)):

PIGO (Phosphatidylinositol Glycan Anchor Biosynthesis, Class O):

NDFIP2 (Nedd4 Family Interacting Protein 2):


Sie sind hier: